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        The effi   ciency of antimicrobial host defense in 
the human intestinal tract relies on the capacity 
of the mucosal immune system to recognize 
and neutralize pathogens. In this context of 
innate immunity, sensing of the bacteria oc-
curs mainly through engagement of host cell 
Toll-like receptors (TLRs) and other pattern-
recognition molecules, such as the nucleotide 
oligomerization domain proteins, by pathogen-
associated molecular patterns (  1  –  3  ). After the 
pathogen recognition step, the subsequent an-
timicrobial response is achieved by recruitment 
of immune cells and synthesis of antimicrobial 
factors by the injured mucosa, including pro-
duction of molecules such as defensins, catheli-
cidins, lysozyme, phospholipases, and proteases 
that exhibit a broad range of actions against a 
variety of pathogens (  4, 5  ). 
  Among antimicrobial factors, defensins rep-
resent a family of cationic molecules with a 
characteristic     -sheet  –  rich fold and a framework 
of six disulphide-linked cysteines (  4, 6  ). The two 
major human defensin subfamilies,     - and     -
defensins, diff  er in the length of peptide segments 
between the six cysteines and the pairing of the 
cysteines that are connected by disulphide bonds. 
Like defensins, the human cathelicidin LL37 
peptide is rich in positively charged amino acid 
residues (  7  ). Production by epithelial cells of 
the best known     -defensins, hBD-1  –  4 and 
cathelicidin LL37, is either constitutive or induc-
ible in response to a proinfl  ammatory situation. 
The expression of HBD1 (formally DEFB1) 
and HBD4 (DEFB104) genes seems to be es-
sentially constitutive, whereas HBD2 (DEFB4), 
HBD3 (DEFB103), and LL37 gene expression 
is inducible in response to various signals, such 
as bacteria, pathogen-associated molecular 
patterns, or proinfl  ammatory cytokines (  6, 8  ). 
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  Antimicrobial factors are effi  cient defense components of the innate immunity, playing a 
crucial role in the intestinal homeostasis and protection against pathogens. In this study, 
we report that upon infection of polarized human intestinal cells in vitro, virulent   Shigella 
fl  exneri   suppress transcription of several genes encoding antimicrobial cationic peptides, 
particularly the human     -defensin hBD-3, which we show to be especially active against 
  S. fl  exneri  . This is an example of targeted survival strategy. We also identify the MxiE bacte-
rial regulator, which controls a regulon encompassing a set of virulence plasmid-encoded 
effectors injected into host cells and regulating innate signaling, as being responsible for 
this dedicated regulatory process. In vivo, in a model of human intestinal xenotransplant, 
we confi  rm at the transcriptional and translational level, the presence of a dedicated MxiE-
dependent system allowing   S. fl  exneri   to suppress expression of antimicrobial cationic 
peptides and promoting its deeper progression toward intestinal crypts. We demonstrate 
that this system is also able to down-regulate additional innate immunity genes, such as 
the chemokine CCL20 gene, leading to compromised recruitment of dendritic cells to the 
lamina propria of infected tissues. Thus,   S. fl  exneri   has developed a dedicated strategy to 
weaken the innate immunity to manage its survival and colonization ability in the intestine. 1122 SUBVERSION OF THE INNATE IMMUNITY BY   SHIGELLA   | Sperandio et al.
gonorrhoeae   (  24, 25  ). Thus, modulation of the innate defense 
system may be a general mechanism facilitating invasion of 
pathogenic bacteria at mucosal surfaces. 
  In this study, by combining in vitro and in vivo approaches, 
we clearly demonstrate that   S. fl  exneri   actively dampens host 
innate immune responses by suppressing transcription of spe-
cifi  c antimicrobial peptide genes. We also identify the bacte-
rial eff  ectors controlled by the MxiE transcriptional activator 
as the molecules responsible for this mechanism. In vivo, the 
strategy used by   S. fl  exneri   to modulate transcription of these 
target genes was followed by a decrease in the production of 
these epithelial cell  –  encoded peptides, coupled to a deeper 
progression of denser population of luminal bacteria toward 
crypts. We demonstrate that MxiE-dependent eff  ectors are 
also able to down-regulate additional innate immunity genes, 
such as chemokine genes, leading to a negative regulation of 
the DCs recruitment to the lamina propria of infected human 
tissues. The production of antimicrobial molecules and 
recruitment of immune cells is one of the major immune 
responses dedicated to the protection of the mucosal sur-
faces, thus, this work highlights the strategy developed by 
  S. fl  exneri   to subvert the dynamic defense processes of the 
intestinal epithelium. 
    RESULTS   
  Virulent   S. fl  exneri   modulates expression of specifi  c innate 
immunity genes in vitro 
  To investigate whether   S. fl  exneri   modulates expression of genes 
involved in the intestinal innate immune response, such as 
the genes encoding antimicrobial factors, we established 
an in vitro model of infection based on polarized and diff  er-
entiated TC7 or HT29 colonic epithelial cells. This model 
mimics the epithelial lining and allows detection of transcripts 
for antimicrobial factors whose expression are correlated with 
the degree of cellular diff  erentiation (  26  ). Infections were 
performed on cell monolayers for 1 h 30 min with the invasive 
wild-type   S. fl  exneri   strain M90T and its isogenic derivatives: 
the invasive   mxiE   mutant, the noninvasive   mxiD   mutant, and 
the noninvasive plasmid-cured BS176 strain. The   mxiE   mutant 
is impaired for the MxiE transcriptional activator regulating 
expression of several virulence factors, such as the Osp and 
IpaH proteins, encoded by the virulence plasmid and injected 
into cells upon infection, whereas the   mxiD   mutant is im-
paired for the assembly of a functional TTSS. The infection 
was stopped by addition of gentamicin. Host cell RNAs were 
harvested at 1 h 30 min, 3 h, and 4 h 30 min after infection 
and analyzed by qRT-PCR for the expression of a selected 
set of innate immunity genes. 
  In noninfected cell monolayers, we observed a basal ex-
pression of the     -defensins HBD1, HBD2, and HBD3, cat-
helicidin LL37, chemokine CCL20, and chemokine receptor 
CCR6-encoding genes. In contrast, we were unable to de-
tect transcription of the     -defensin HBD4 gene in all tested 
conditions, including infection experiments (unpublished 
data). Infection of TC7 or HT29 cells with the noninvasive 
  mxiD   or BS176 strains was followed by strong transcriptional 
Permeabilization of target membranes is the crucial step in 
defensin-mediated antimicrobial activity and cytotoxicity (  9  ). 
In bacteria, this phenomenon coincides with inhibition of 
RNA, DNA, protein synthesis, and a decrease in bacterial 
viability (  10  ). 
  Antimicrobial factors have been linked to the bridging of 
innate and acquired immune responses. Indeed, cathelicidin 
and various     -defensins show chemotactic activity for immune 
cells such as monocytes, T cells, or immature DCs, and can 
induce cytokine production by monocytes and epithelial cells 
(  11, 12  ). Several pieces of evidence indicate that some activ-
ities of defensins are receptor mediated, resulting in activation 
of downstream signaling events. Indeed, it has been demon-
strated that the chemotactic activity of hBD-1, -2, and -3 for 
memory T cells and immature DCs is mediated through bind-
ing to the chemokine receptor 6 (CCR6), which is the recep-
tor for the chemokine (C-C motif) ligand 20 (CCL20) (  12  ). 
Conversely, some molecules with chemotactic properties for 
immune cells, such as chemokine CCL20, exhibit antimicrobial 
activity against various Gram-positive and -negative bacteria 
(  13  ). The rapid expression of antimicrobial factors is thus cor-
related to the recruitment of adaptative immune cells capable 
of directing a long-lasting cellular response to pathogens (  11  ). 
  Among enteric pathogens, virulent   S. fl  exneri   are highly 
contagious Gram-negative enteroinvasive bacteria that cause 
bacillary dysentery. In malnourished toddlers in the developing 
world, untreated infections can be fatal.   S. fl  exneri   is unable to 
invade intestinal epithelial cells through the apical surface, but 
needs to translocate the intestinal epithelium for the develop-
ment of infection (  14  ). The pathogen translocates through 
M cells of the follicle-associated epithelium that covers the 
lymphoid nodules associated with the colonic mucosa. In the 
subepithelial location,   S. fl  exneri   causes apoptosis of resident 
macrophages, allowing bacterial escape into the tissues and 
effi   cient basolateral entry into epithelial cells, followed by cell  –
  cell spread and effi   cient intracellular growth (  15, 16  ). Subse-
quent infl  ammation destroys cohesion of the epithelial barrier, 
facilitating further invasion of luminal bacteria and propaga-
tion of the infection (  17  ). These complex processes are orches-
trated by bacterial eff  ectors that are encoded by plasmid-located 
gene clusters and are injected into cells through a type III se-
cretion system (TTSS) (  18  ). Under conditions of secretion, 
expression of 12 of these genes is controlled by MxiE, a tran-
scriptional activator of the AraC family (  19  ). MxiE-dependent 
proteins are thought to be essential for the infection process, 
as exemplifi  ed by OspF and OspG, which negatively regulate 
the host innate immune response induced by   S. fl  exneri   upon 
invasion of the epithelium (  20, 21  ). 
  In the course of the invasion of the human intestinal epi-
thelial lining,   S. fl  exneri   is confronted by the surface antimi-
crobial innate defense systems. Recent studies reported that 
  S. fl  exneri   may interfere with this host barrier defense system 
by down-regulating expression of genes from the innate im-
mune response such as HBD1 and LL37 (  22, 23  ). This immune 
escape strategy may also be used by other human pathogens, 
such as   Salmonella enterica   serovar Typhimurium and   Neisseria JEM VOL. 205, May 12, 2008 
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induction of HBD2, HBD3, LL37, CCL20, and CCR6 genes, 
over their basal level that could be observed as early as 1 h 
30 min after infection, whereas the HBD1 gene remained 
expressed at its basal level of expression throughout the ex-
periments (unpublished data). 
  In our experimental conditions, the invasive wild-type 
strain M90T was unable to signifi  cantly invade polarized and 
diff  erentiated cell monolayers, as assessed by gentamicin as-
says (  Fig. 1 C  ), which is in agreement with data obtained in 
apically infected polarized Caco-2 cells (  14  ).   However, infec-
tion experiments with strain M90T showed diff  erential tran-
scriptional expression of the HBD3 and CCR6 genes in both 
cell types, and for the LL37 gene in TC7 cells only, com-
pared with infections with the noninvasive   mxiD   and BS176 
strains (  Fig. 1, A and B  ). At 4 h 30 min after infection, tran-
scription of these genes in infected cells was induced to a 
lesser extent by the wild-type strain M90T compared with 
the   mxiD   and BS176 strains. In TC7 cells, the HBD3 gene 
expression was induced only 4-fold by M90T compared with 
  >  110-fold by BS176 (  Fig. 1 A  ). Conversely, expression of 
HBD1, HBD2, and CCL20 genes was found to be similar for 
all infections with the two cell lines (  Fig. 1, A and B  ). As a 
control, cellular viability was the same for monolayers infected 
with the wild-type   S. fl  exneri   strain and its derivatives, as as-
sessed by lactate dehydrogenase assays (  Fig. 1 D  ). Collectively, 
these results indicate that wild-type   S. fl  exneri   impairs expression 
of specifi  c innate immunity genes by injecting virulence fac-
tors into epithelial cells through its TTSS, thereby aff  ecting 
the host immune response. 
  The   S. fl  exneri   MxiE regulon includes   >  10 virulence pro-
teins delivered through the TTSS upon contact of the bacteria 
with cells. Among them, the OspF and OspG eff  ectors have 
been shown to target the host NF-    B and mitogen-activated 
protein kinase (MAPK) signaling pathways (  20, 21, 27, 28  ). 
Expression of the genes encoding these proteins is dramati-
cally aff  ected in a   mxiE   mutant, therefore preventing their 
synthesis and injection into cells upon infection (  19  ). How-
ever, the   mxiE   mutant still has a functional TTSS for injec-
tion of the MxiE-independent eff  ectors, allowing an effi   cient 
invasion of nonpolarized epithelial cells, comparable to the 
M90T wild-type strain (  19, 47  ). To determine whether the 
pool of MxiE-dependent eff  ectors was involved in the host 
innate immunity gene  ’  s down-regulation, we carried out in-
fection experiments with the invasive   mxiE   mutant. Like ob-
served for the wild-type strain M90T, the   mxiE   mutant was 
unable to signifi  cantly invade polarized and diff  erentiated TC7 
or HT29 cells (  Fig. 1 C  ). However, in contrast to M90T, the 
  mxiE   mutant was unable to modulate transcription of HBD3, 
LL37, and CCR6 genes in infected cell monolayers (  Fig. 1, 
A and B  ). Transcription of these genes, as well as of the other 
    Figure 1.     Virulent   S. fl  exneri   modulates transcription of innate 
immunity genes in polarized colonic epithelial cells.   (A and B) Expres-
sion of     -defensins HBD1, HBD2, and HBD3, cathelicidin LL37, chemokine 
CCL20, and chemokine receptor CCR6 encoding genes was determined in 
TC7 (A) or HT29 (B) cell monolayers 4 h 30 min after infection (3 h after 
gentamicin addition). After RNAs extractions and RT reactions, qRT-PCR 
was performed on each sample with specifi  c primers to determine the 
relative expression of genes in each condition, using the comparative Ct 
method. Results are presented on a logarithmic scale as the ratio of gene 
expression in infected cells compared with noninfected cells. Black bars, 
wild-type strain M90T; gray bars, plasmid-cured BS176 strain; white bars, 
  mxiD   mutant strain; striped bars,   mxiE   mutant strain. *, P   <   0.01 for 
infections with the wild-type strain compared with the other strains. 
(C)   S. fl  exneri   is unable to signifi  cantly invade polarized and differentiated 
TC7 or HT29 epithelial cells. Gentamicin assays were performed in 6-well 
plates (1.5   ×   10  6   cells/well), at a MOI of 100, in conditions similar to those 
used for infection experiments (time course: 1 h 30 min). Values represent 
the percentage of intracellular CFU. Black bars, TC7 cells; gray bars, HT29 
cells. (D) Cellular viability is the same for TC7 or HT29 cell monolayers 
infected with the wild-type   S. fl  exneri   strain and its derivatives. Lactate 
dehydrogenase assays were performed in 6-well plates (1.5   ×   10  6   cells/well), 
at a MOI of 100, in conditions similar to those used for infection experi-
ments (time course: 1 h 30 min). Values represent the percentage of 
cell death. Black bars, TC7 cells; gray bars, HT29 cells.   n  = 3 independent 
biological experiments. Error bars represent the SD.     
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weak down-regulation was observed for CCR6 gene expression 
(  Fig. 2  ). Interestingly, the wild-type   S. fl  exneri   strain M90T 
conserved its capacity to actively repress HBD3 gene ex-
pression in IL-1      –  stimulated cells (  Fig. 2  ). As expected, the 
  mxiE   mutant strain, as well as the   mxiD   and BS176 strains, 
were still unable to modulate HBD3 gene induction in IL-1      –
  treated cells (  Fig. 2  ). Similarly, wild-type bacteria repressed 
CCR6 gene transcription in stimulated cells, whereas   mxiD   
and   mxiE   mutants failed to dampen its expression in similar 
conditions (  Fig. 2  ). Collectively, these in vitro results indicate 
that virulent   S. fl  exneri   manipulates the host innate immune 
response through injection of the MxiE-dependent eff  ectors, 
genes studied, was similar in cells upon   mxiE  ,   mxiD  , or BS176 
infection (  Fig. 1, A and B  ). In addition, infection experi-
ments performed with mutant strains defective for the   ospF   
or   ospG   genes revealed that the encoded eff  ectors repressed 
antimicrobial factor genes transcription (unpublished data). 
However, the extent of repression was inferior to the one 
observed with the whole set of eff  ector proteins delivered by 
the M90T strain, suggesting additive synergistic action of these 
eff  ectors to get full repression of the antimicrobial peptide genes 
expression. Thus, the pool of MxiE-dependent eff  ectors in-
jected in cells upon infection is responsible for the observed 
manipulation of the host immune response through transcrip-
tional dampening. 
  Expression of several genes of the innate immune re-
sponse is known to be up-regulated in intestinal epithelial cells, 
by treatment with proinfl  ammatory molecules such as IL-1    , 
TNF-    , or IFN-     (  4  ). To determine whether   S. fl  exneri   was 
still able to modulate transcription of innate immunity genes 
in cells induced to undergo an infl  ammatory response pattern, 
TC7 cell monolayers were stimulated by IL-1     for 2 h, the 
IL-1      –  containing medium was removed, and   S. fl  exneri   infec-
tions were performed. IL-1     treatment was followed by an 
induction of the HBD2, HBD3, and CCL20 genes transcrip-
tion in noninfected cells (  Fig. 2  ).   In the same conditions, ex-
pression of the HBD1 gene remained unchanged, whereas a 
    Figure 2.       S. fl  exneri   modulates transcription of innate immunity 
genes in cells expressing an infl  ammatory response pattern.  Ex-
pression of the     -defensins HBD1, HBD2, and HBD3, cathelicidin LL37, 
chemokine CCL20, and chemokine receptor CCR6 encoding genes was 
determined at 4 h 30 min after infection (3 h after gentamicin addition) 
in TC7 cells that were prestimulated for 2 h by IL-1    . After RNA extrac-
tions and reverse transcription reactions, qRT-PCR was performed on each 
sample with specifi  c primers to determine the relative expression of genes 
in each condition, using the comparative Ct method. Results are presented 
on a logarithmic scale as the ratio of gene expression in stimulated and 
infected cells compared with nonstimulated and noninfected cells. Light 
gray bars, noninfected; black bars, wild-type strain M90T; gray bars, plasmid-
cured BS176 strain; white bars,   mxiD   mutant strain; striped bars,   mxiE  
mutant strain.   n  = 3 independent biological experiments. Error bars repre-
sent the SD. *, P   <   0.01 for infections with the wild-type strain compared 
with the other strains.     
    Figure 3.     Antimicrobial factors whose transcription is repressed by 
  S. fl  exneri   are those affecting highest bactericidal activity against 
the pathogen.   (A) Bactericidal activities of synthetic    -defensins  hBD-1, 
hBD-2, and hBD-3, cathelicidin LL37, or recombinant chemokine CCL20 
were determined on   S. fl  exneri   exponential cultures growing in DME 
medium for 2 h at 37  °  C. hBD-1, hBD-2, hBD-3, and LL37 were used at 
50   μ  g/ml, whereas CCL20 was used at 5   μ  g/ml fi  nal concentration. Values 
expressed in arbitrary fl  uorescent units (afu) represent the mean fl  uo-
rescence of the bacterial population analyzed. Black bars, wild-type strain 
M90T; gray bars, plasmid-cured BS176 strain; white bars,   mxiD   mutant 
strain; striped bars,   mxiE   mutant strain. *, P   <   0.01 for the fl  uorescence 
obtained with the BS176 strain compared with the other strains. (B)   L. mono-
cytogenes   and   L. innocua   were used as positive controls for antimicrobial 
activity of these factors ineffi  cient on   S. fl  exneri   in our experimental con-
ditions. Black bars,   L. monocytogenes  ; gray bars,   L. innocua .   n  = 3 inde-
pendent experiments. Error bars represent the SD.     JEM VOL. 205, May 12, 2008 
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wild-type strain M90T and its derivatives   mxiD  ,   mxiE  , and 
BS176, were sampled in the exponential phase, resuspended, 
and cultured for 2 h in 1:2 diluted DME culture medium 
(salts 0.08 M, pH 7.2; no serum) containing the relevant an-
timicrobial peptide. The DiBAC fl  uorescent reagent that is 
able to cross-depolarize bacterial membranes was added to 
cultures, followed by FACS analysis of bacterial fl  uorescence 
(mean fl  uorescence) (  29  ). 
  In these conditions,     -defensins hBD-1 and -2 were 
  inactive on the   S. fl  exneri   wild-type strain and its derivatives, as 
assessed by the weak fl  uorescence values obtained (  Fig. 3 A  ).   
Conversely, the     -defensin hBD-3 exhibited strong bactericidal 
activity on the pathogen at a similar concentration (  Fig. 3 A  ). 
Interestingly, the plasmid-cured BS176 strain was twofold more 
sensitive to hBD-3 than the other strains, as confi  rmed by 
CFU assays (unpublished data), suggesting that proteins en-
coded by the virulence plasmid achieve higher bacterial resis-
tance to this antimicrobial factor. To explore the possibility 
of plasmid-encoded proteolytic degradation of hBD-3, we 
even in cells already expressing an infl  ammatory pattern, a 
situation that is likely to prevail in the dynamics of inter-
actions between luminal bacteria and the epithelial lining in 
the course of an infection. 
  Antimicrobial factors whose transcription is repressed 
by   S. fl  exneri   are those affecting the highest bactericidal 
activity against the pathogen 
  To measure the antimicrobial activity of innate immune fac-
tors such as     -defensins hBD-1, hBD-2, and hBD-3, catheli-
cidin LL37, and chemokine CCL20 on   S. fl  exneri   viability, we 
determined the in vitro antimicrobial activity of each of these 
peptides against the pathogen, using synthetic or recombi-
nant molecules. Typically, the conditions used for demon-
strating activity of antimicrobial peptides include buff  ers of 
low ionic strength and neutral pH that allow for optimal kill-
ing because the activity of most antimicrobial factors is antag-
onized by high salt concentrations, the presence of divalent 
cations, and serum components (  4  ). For this purpose, the 
    Figure 4.       S. fl  exneri   manipulates expression of genes from the innate immune response in human intestinal xenografts.   (A) Human tissues 
were infected for 2 h by direct intraluminal inoculation with 5   ×   10  7   bacteria. Total RNA was extract from a section of each infected grafts, cRNA were 
synthesized and hybridized on the Affymetrix U133A GeneChip Human Array. Gene expression profi  les from two experiments corresponding to the nonin-
fected condition (NI), BS176 infection (BS176), M90T infection (M90T), and   mxiE   infection  ( mxiE  ), are shown. Hierarchical clustering of immunity genes 
was performed using dChip software with Euclidian distance and average as a linkage method. Before clustering, expression values for one gene across all 
samples were standardized to produce a mean of zero. Increased or decreased values were then ranged compared with that mean. Red and blue colors 
represent expression that is higher or lower than the mean value, respectively. The key for intensity of expression is indicated under the bar. (B) Validation/
determination by qRT-PCR of     -defensins HBD1, HBD2, and HBD3, cathelicidin LL37, chemokine CCL20, and chemokine receptor CCR6 genes expression 
in infected tissues used for GeneChip experiments. After reverse transcription reactions, qRT-PCR was performed on each sample with specifi  c primers to 
determine the relative expression of genes in each condition using the comparative Ct method. Results are presented on a logarithmic scale as the ratio 
of gene expression in infected tissues compared with noninfected tissues. Black bars, wild-type strain M90T; gray bars, plasmid-cured BS176 strain; 
striped bars,   mxiE   mutant strain.   n   = 2 independent biological replicates per condition.     1126 SUBVERSION OF THE INNATE IMMUNITY BY   SHIGELLA   | Sperandio et al.
cifi  cally focused our attention on genes encoding chemokines, 
cytokines, and antimicrobial peptides (  Fig. 4 A  ).   Validation 
of data were performed on a set of genes, including HBD2 
and HBD3, whose probe sets were absent from the used arrays, 
using qRT-PCR (  Fig. 4 B  ). From this gene cluster, we iden-
tifi  ed a total of 46 genes whose expression was signifi  cantly 
modulated by   S. fl  exneri   in infected intestinal xenotransplants. 
  Interestingly, 11 genes were less transcribed upon infec-
tion with the wild-type strain M90T compared with the 
invasive   mxiE   mutant or the noninvasive BS176 strain (  Fig. 
4, A and B  ). These targets of the MxiE-dependent eff  ectors 
included genes encoding chemokines and chemokine recep-
tors, such as CCL3, CCL4, CCL20, CCL25, and CCRL2. 
Mainly produced by epithelial cells, these proteins are involved 
in the recruitment and activation of infl  ammatory and im-
mune eff  ectors cells such as monocytes, DCs, and T cells (  31  ). 
Expression of genes encoding cytokines IL-7 and -18 and 
cytokine receptors IL-13RA1 and -20RA was also less ex-
pressed in human tissues infected by the M90T strain com-
pared with the   mxiE   mutant. IL-7 is produced locally by 
intestinal epithelial and goblet cells, and may serve as a reg-
ulatory factor for intestinal mucosal lymphocytes, whereas 
IL-18 induces IFN-     production by T cells. Finally, among 
down-regulated genes, as measured by qRT-PCR, expression 
of     -defensins HBD1 and HBD3 was strongly reduced in 
xenotransplants infected by wild-type bacteria compared with 
  mxiE   mutants; ratios were 0.09:1.09 for HBD1 and 0.1:0.82 
for HBD3, respectively (  Fig. 4, A and B  ). 
  In addition to down-regulating the expression of several 
genes encoding chemokines, cytokines, and antimicrobial pep-
tides, transcriptional analysis indicated that MxiE-dependent 
bacterial eff  ectors up-regulate the expression of the SOCS2 
gene (  Fig. 4 A  ). Interestingly, members of this family are 
cytokine-inducible negative regulators of cytokine signaling 
pathways whose primary function is to attenuate JAK  –  STAT 
tested the activity of the defensin in the presence of   S. fl  exneri   
mutants defective for the expression of the surface/secreted 
proteases SepA or SopA that are encoded by the virulence 
plasmid, and the   sepA  -BS176  –  complemented strain (  18, 30  ). 
No change in bacterial sensitivity was observed with any of the 
mutant strains, suggesting that   S. fl  exneri   is unlikely to proteo-
lytically degrade the antimicrobial factors (unpublished data). 
Finally, among the antimicrobial factors tested, cathelicidin 
LL37 and chemokine CCL20 exhibited an intermediary an-
tibacterial action on   S. fl  exneri   compared with hBD-1-2 and 
hBD-3 (  Fig. 3 A  ). As a control of our experimental condi-
tions,   Listeria monocytogenes   and   Listeria innocua   were tested 
and found to be sensitive to all the antimicrobial peptides 
tested, except for cathelicidin LL37, at equivalent concentra-
tions (  Fig. 3 B  ). Collectively, these results show that among 
the molecules tested in vitro, the most active antimicrobial 
factors for   S. fl  exneri   are those whose expression is repressed 
by the virulent bacterium at the transcriptional level. 
    S. fl  exneri   regulates expression of innate immunity genes 
in vivo 
  To confi  rm in vivo that virulent   S. fl  exneri   down-regulates 
expression of antimicrobial factors, we performed a transcrip-
tomic analysis of xenotransplanted human intestinal segments 
after infection for 2 h by the wild-type strain M90T, the 
  mxiE   mutant, and the avirulent strain BS176. Xenografts in-
jected with bacterial medium alone were used as a reference. 
Xenotransplants exhibit a chimerical structure, combining es-
sentially human intestinal epithelium and mouse vascular and 
immune cells. Infection of these tissues for short time periods 
allowed for the study of gene transcription in human epithe-
lial cell, thanks to the use of human-specifi  c arrays. Two in-
dependent array hybridization experiments were performed 
for each condition, and the hierarchical clustering of modu-
lated gene expression was determined. Among them, we spe-
    Figure 5.       S. fl  exneri   blocks hBD-1, hBD-3, and CCL20 expression in human intestinal xenografts.  Anti – human  hBD-1  (A  and  B),  anti – human 
hBD-3 (C and D), and anti  –  human CCL20 (E and F) immunostainings of human intestinal xenograft sections after 2 h of infection with the wild-type 
  S. fl  exneri   strain M90T (A, C, and E) or the   mxiE   mutant (B, D, and F). Arrows indicate the poor luminal release of hBD-1 (A), hBD-3 (C), and CCL20 (E) by 
epithelial cells, typically observed in tissues infected by wild-type bacteria. Arrowheads highlight areas of extensive release of hBD-1 (B), hBD-3 (D), and 
CCL20 (F) by epithelial cells, typically found in   mxiE  -infected tissues.   n  = 4 independent biological replicates per condition. Bars, 10   μ  m.     JEM VOL. 205, May 12, 2008 
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plants was observed only in few occasions (unpublished data). 
However, the strong epithelial expression of antimicrobial 
factors observed at the same time indicates the establishment 
of a mucosal infl  ammatory response (  Fig. 5   and Fig. S1). This 
situation prompted us to study how the epithelial infl  amma-
tory response aff  ected the behavior of bacteria at the mucosal 
surface, especially their ability to progress toward crypts through 
intervilli spaces. For this purpose, we performed a qualitative 
and quantitative analysis of the bacterial distribution from the 
top of the villi to the crypts of xenotransplants infected for 2 h 
with the wild-type strain M90T or with the   mxiE   and   mxiD   
mutants. Qualitatively,   S. fl  exneri   5a LPS immunostainings 
revealed that wild-type bacteria were distributed more dif-
fusely in the mucus layer than   mxiE   and   mxiD   mutants, whose 
localization remained close to the top of the villi, essentially 
trapped in the luminal mucus (  Fig. 6, A  –  C  ).   In addition, 
  mxiE   and   mxiD   mutants were barely seen localized in luminal 
intervilli spaces or deep near the crypts, compared with wild-
type bacteria that aff  ected a much deeper diff  usion pattern 
(  Fig. 6, A-C  ). Quantitatively, the amount of M90T bacteria 
signaling. In turn, a potential role of the JAK  –  STAT signal-
ing pathway in down-regulating expression of HBD1 and 
HBD3 has been suggested (  32  ). Collectively, these in vivo 
results show that   S. fl  exneri   is able to manipulate the host in-
nate immune response through its MxiE-dependent eff  ectors 
by up- or down-regulating expression of crucial innate im-
munity genes. 
    S. fl  exneri   blocks antimicrobial factors expression in vivo 
  Our study so far has shown that MxiE-dependent   S. fl  exneri   
eff  ectors modulate expression of a subset of genes encoding 
molecules involved in the host innate immune response. There-
fore, we investigated the in vivo consequences of this strategy 
in intestinal tissues infected by the pathogen. For this pur-
pose, xenotransplants were infected for 2 h with the wild-type 
strain M90T, the   mxiE   mutant, the noninvasive   mxiD   mutant 
harboring an inactive TTSS, or injected with bacterial cul-
ture medium alone as control. Immunolabelings were per-
formed on infected tissues with antisera to human     -defensins 
hBD-1, hBD-3, and chemokine CCL20. Noninfected tis-
sues revealed weak staining for hBD-1 and no labeling for 
hBD-3 and CCL20, which is in agreement with the respective 
constitutive and inducible production of these molecules by 
epithelial cells in vivo (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20071698/DC1). Interestingly, 
in tissues infected by the wild-type strain M90T, hBD-1 and -3 
staining exhibited a weak labeling after the villi contours, sug-
gesting poor synthesis and release of these molecules in the lu-
men (  Fig. 5, A and C  ).   Conversely, in   mxiE   mutant-infected 
tissues, massive luminal release of these antimicrobial peptides 
was observed from epithelial cells exposed to the colonizing 
bacteria, imprinting the portion of the mucus layer proximal to 
the epithelial surface (  Fig. 5, B and D  ). As expected for their 
profi  le,     -defensin hBD-2 immunostainings were similar 
in human xenografts infected by wild-type and   mxiE   mutant 
bacteria (unpublished data). In agreement with the transcrip-
tional data from xenografts, CCL20 labeling showed strong 
production of this chemokine by enterocytes along villi with 
luminal effl   ux in the transplants infected by the   mxiE   strain, 
whereas only a weak signal was detected in tissues infected by 
the M90T strain (  Fig. 5, E and F  ). Other defensin- and chemo-
kine-staining experiments indicated a similar staining pattern 
for   mxiD  - compared with   mxiE  -infected xenografts (Fig. S1, B, 
D, and F). Collectively, these experiments indicate that MxiE-
dependent   S. fl  exneri   eff  ectors aff  ect the production of hBD-1, 
hBD-3, and CCL20 molecules exhibiting antimicrobial ac-
tivities, thereby weakening the antimicrobial defense barrier at 
infected mucosal surfaces. 
  Blocking of antimicrobial factor expression correlates with 
deeper progression of   S. fl  exneri   toward intestinal crypts 
  Such epithelial cell manipulation for antimicrobial factor ex-
pression may represent a critical mechanism allowing   S. fl  exneri   
to more deeply colonize and invade the mucosa. At 2 h after 
infection, the presence of the M90T wild-type strain and the 
  mxiE   mutant in the lamina propria of infected xenotrans-
    Figure 6.     Blocking of antimicrobial peptides expression correlates 
with deeper progression of   S. fl  exneri   toward intestinal crypts.   Anti –
  S. fl  exneri   5a LPS immunostainings of human intestinal xenograft sections 
after 2 h of infection with the wild-type   S. fl  exneri   strain M90T (A), the 
  mxiE   (B), or the   mxiD   (C) mutant strains. Arrow indicates the M90T bacte-
ria diffusely distributed in the mucus layer from the top of the villi to the 
crypts (A). Arrowheads highlight the   mxiE   and   mxiD   mutants  localized 
close to the top of the villi or engulfed into the luminal mucus (B and C). 
(D) Bacterial counts in the mucosal tissue. The anti  –    S. fl  exneri   5a LPS im-
munostaining sections were used to count the bacteria localized at the 
top of the villi (upper third), in the luminal intervilli spaces (intermediate 
third), and in the crypts (lower third). A representative set of 10 villi per 
section was analyzed, and three sections were read for four independent 
biological replicates per condition. Results are presented as a percentage 
of the amount of bacteria found at each location. The 100% is defi  ned by 
the amount of M90T bacteria determined at the upper third of the villi. 
Black bars, wild-type strain M90T; striped bars,   mxiE   mutant strain; white 
bars,   mxiD   mutant strain.   n  = 4 independent biological replicates per con-
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as a poor migration into the lamina propria with much less 
staining than observed in noninfected tissues for resident DCs 
(  Fig. 7, A and C  ). Collectively, these experiments highlight 
the existence of a dedicated MxiE-dependent system allow-
ing   S. fl  exneri   to suppress expression of immune eff  ectors, 
leading to compromised recruitment of DCs to the lamina 
propria of infected tissues. 
    DISCUSSION   
  The human intestinal epithelium achieves a barrier function 
between the host  ’  s   “  milieu int  é  rieur  ”   and the outside environ-
ment, particularly the gut microbiota. This barrier protects 
against invasion and systemic dissemination of both commensal 
and pathogenic microorganisms. The epithelium can be seen 
as comprising three barriers in one: a physical barrier, an in-
nate immune barrier, and an adaptive immune barrier (  33  ). 
Accessibility to the apical surface of epithelial cells and rup-
ture of the physical barrier are among the main properties 
that distinguish pathogens from commensals. Among the nu-
merous factors that participate in establishment and mainte-
nance of epithelial homeostasis, antimicrobial factors that are 
ubiquitously expressed by epithelial cells throughout the gas-
trointestinal tract play an important regulatory role in con-
trolling the resident and transient bacterial populations (  34  ). 
Moreover, epithelial cells and DCs act as sentinels at mucosal 
surfaces and secrete chemokines that recruit, activate, and reg-
ulate infl  ammatory infi  ltrates, including polymorphonuclear 
leukocytes transmigrating through the epithelium, resident 
macrophages, recruited monocytes, and a variety of lympho-
cytes. These effectors participate in the innate response to 
commensals under steady-state conditions, a situation of tol-
erance that commensals themselves actively maintain (  35  ). In 
addition to maintaining effi   cient physical and innate immune 
barrier functions, the intestinal epithelium also takes an active 
part in the induction of adaptive immune surveillance at the 
mucosal surface. After sampling luminal bacteria, DCs mi-
grate to mesenteric lymph nodes and initiate an adaptive im-
mune response directing specifi  c IgA production in the lamina 
propria (  36  ). Mucosal defense mechanisms also encompass 
cellular factors, including B and T cells, and lymphocytes unique 
to the gut-associated lymphoid tissues, such as lamina propria 
lymphocytes (  37  ). 
  However, homeostasis of the epithelial barrier can be 
subverted by crosstalks between enteric bacterial pathogens 
and mucosal tissues. The genetic make up of bacterial enteric 
pathogens can therefore be seen in the perspective of a co-
evolutionary process that has led to the presence of genes and 
pathogenicity island encoding effectors able to disrupt this 
homeostatic process and to resist to its essentially infl  ammatory 
consequences. Because antimicrobial peptides appear to be 
primary eff  ectors throughout evolution to fi  ght microbes and 
represent in the vast majority of species, particularly in in-
sects, the fi  rst line of defense in the absence of an adaptive 
immune response (  38  ), it would not be surprising if the genome 
of pathogens such as   S. fl  exneri   had evolved to respond to this 
vital constraint. How this is achieved is just being unraveled. 
observed in the lower third of the villi, including the crypt 
areas, was close to the half of the one determined at the upper 
third (  Fig. 6 D  ). Collectively, these results highlight the cor-
relation existing between the ability of virulent   S. fl  exneri   to 
block antimicrobial factors expression, and their capacity to 
progress deeply and massively toward intestinal crypts, at the 
early time point of infection. 
    S. fl  exneri   compromises recruitment of DCs to the lamina 
propria of infected tissues 
  The     -defensins hBD-1 and -3, and the chemokine CCL20, 
are immune eff  ectors known to have both antimicrobial 
properties and chemotactic activities. Our study so far has 
shown that the blocking of their expression at the mucosal 
surface by   S. fl  exneri   was coupled to deeper progression of 
bacteria toward crypts. To correlate these fi  ndings to mouse 
immune cell traffi   cking, additional immunostaining experi-
ments were performed using a monoclonal antibody to mouse 
CD11c, one of the main antigens present on the surface of 
DCs. CD11c staining of   mxiE  -infected tissues revealed mas-
sive recruitment of DCs into the lamina propria and submu-
cosal regions; they are probably attracted by the gradient of 
chemotactic molecules, such as CCL20, emanating from epi-
thelial cells (  Fig. 7 B  ).   Similar observations were obtained in 
  mxiD  -infected tissues (  Fig. 7 D  ). In contrast, M90T-infected 
xenotransplants showed a very diff  erent pattern characterized 
by a restricted presence of DCs in submucosal areas, as well 
    Figure 7.       S. fl  exneri   compromises the DCs recruitment in human 
intestinal xenografts.  Anti – mouse  CD11c  immunostainings  of  human 
intestinal xenograft sections after 2 h of infection with the wild-type 
  S. fl  exneri   strain M90T (A), the   mxiE   mutant (B), the   mxiD   mutant (D), or in 
noninfected tissues (C). Arrow indicates the poor DC recruitment in sub-
mucosal areas, as well as in the lamina propria, typically observed in tis-
sues infected by wild-type bacteria (A). Arrowheads highlight the resident 
DC in noninfected tissues (C), or the massive recruitment of DCs into the 
lamina propria and their accumulation in submucosal regions, typically 
found in tissues infected by the   mxiE   (B) or   mxiD   (D) mutants.   n  = 4 inde-
pendent biological replicates per condition. Bars, 10   μ  m.     JEM VOL. 205, May 12, 2008 
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response elements. Moreover, the inhibition of HBD3 gene 
transcription observed with both the NF-    B inhibitor PDTC 
and the p38 inhibitor suggests the possibility of the existence 
of NF-    B binding motifs (  42  ). As suggested earlier, one could 
even hypothesize that the selective pressure for acquisition of 
the diversity of Osp and possibly IpaH eff  ectors, the latter being 
a new class of E3 ubiquitin ligases with no known substrate as 
yet (  43  ), has been partly driven by the need to transcriptionally 
suppress expression of defense genes whose activation and 
regulation is complex and multifactorial. 
  Antimicrobial peptides exhibit a strong antibacterial ac-
tivity toward Gram-negative and -positive bacteria, as observed 
for hBD-3 on   S. fl  exneri   and   Listeria  , as well as an ability to act 
as chemoattractants for immune cells (  4  ). With such properties, 
it seems logical that pathogens have developed mechanisms 
to resist these immune eff  ectors. The main strategies for patho-
genic bacteria to thwart cationic peptides are to die and act as 
decoys, to degrade them, to block their action, or to suppress 
their expression, particularly at the transcriptional level (  44  ). 
The latter option appears to be the strategy that   S. fl  exneri   has 
evolved, along with other pathogens such as   Salmonella   and 
  Neisseria  , although the mechanisms used by these two pathogens 
to interfere with the host signaling pathways are so far un-
characterized (  24, 25  ). Finding the   S. fl  exneri   eff  ectors and 
the molecular mechanisms that dampen the transcription of 
antimicrobial peptides will lead to a better understanding 
of the complex circuits that induce and regulate their ex-
pression, and will provide another example of the contribution 
of bacterial virulence factors to decipher basic physiological 
mechanisms (  45  ). 
  Exposure of the intestine to microbes maintains steady-
state   “  physiological infl  ammation  ”   at mucosal surfaces, a situ-
ation preventing tissue invasion by commensal microorganisms. 
In this scheme, DCs orchestrate the innate and the adaptive 
immune responses, playing a central role in properly inter-
preting signals that maintain tolerance versus those that should 
trigger a neutralizing adaptive immune response against patho-
gens. As such, pathogenic bacteria have multiple opportu-
nities to subvert the immune response at the level of DCs. 
In this study,   S. fl  exneri   was found to down-regulate innate im-
munity genes such as CCL20, the main DC chemoattractant, 
leading to compromised recruitment of DCs to the lamina 
propria of infected tissues. By blocking the recruitment of DCs 
to the site of infection,   S. fl  exneri   potentially interferes with 
the tolerogenic process, and thus uncontrolled infl  ammation 
that is known to facilitate disruption of the epithelial barrier 
and facilitate further mucosal invasion (  17  ). An inhibition of 
DC recruitment may also strongly interfere with the critical 
step of transition between the innate and adaptive response, 
which will decide upon the switch toward a Th1, Th2, or 
Th17 response, the development of this response, and the 
triggering of immunological memories. These issues are es-
sential to bear in mind for the development of a rationally at-
tenuated live oral vaccine candidate against   S. fl  exneri  . The 
diffi   culty of the equation now appears to maintain a strong 
protection against killing by epithelial defenses to achieve 
Epithelial cells mediate and orchestrate this dialog mainly 
through activation of proinfl  ammatory pathways, particularly 
the NF-    B  –   and activating protein 1- (AP-1) signaling path-
ways (  39  ). To gain access to the epithelial surface, to colonize 
it, and to then possibly disrupt this barrier and invade the 
mucosa, pathogens have evolved strategies to overcome the 
development of antimicrobial immune responses. Pathogenic 
bacteria, such as   S. fl  exneri  ,   Salmonella  , or   Yersinia  , have elabo-
rate strategies targeting specifi  c steps of the NF-    B and MAPK 
pathways that allow them to interfere with the transcription 
of immune response genes from epithelial cells (  20, 39  ). 
  Rectal biopsies from patients with bacillary dysentery re-
vealed that expression of the antibacterial peptides HBD1 and 
LL37 was reduced (  22, 23  ). This was the fi  rst indication that 
  S. fl  exneri   might abrogate expression of some key antimicro-
bial peptides as part of a possibly more global strategy of ma-
nipulating the mucosal innate immune response. Thus, this 
observation needed to be confi  rmed and analyzed in light of 
accumulating data on   S. fl  exneri   pathogenesis, particularly the 
evidence that the TTSS of   S. fl  exneri   allows injection of pro-
tein eff  ectors that have the capacity to target specifi  c steps of 
activation of key innate response pathways, such as the NF-    B 
pathway into epithelial cells. OspG, which is one of the plasmid-
encoded MxiE-regulated proteins, is a kinase that binds a 
limited set of ubiquitinated E2 enzymes, particularly those in-
volved in the degradation of I-    B, thereby blocking their 
function and preventing translocation of the NF-    B complex 
into the nucleus (  21  ). On the other hand, the OspF eff  ector, 
which is a phosphothreonine lyase that reaches the host cell 
nucleus, dephosphorylates the MAPK Erk1/2 and p38, thereby 
leading to the dephosphorylation of histone H3. Subsequent 
epigenetic modifi  cations impair the accessibility of the NF-    B 
complex on a series of promoters (  20, 28  ). The   ospF   and   ospG   
genes are essentially under the control of MxiE, the master 
regulator of the regulon encoding   >  10 plasmid-borne genes 
(  19  ). Their transcription is triggered by activation of the TTSS; 
thus, as soon as bacteria establish contact with target cells, these 
proteins are expressed and secreted into cells that, at the same 
time, undergo strong proinfl  ammatory signaling via the TLR 
and nucleotide oligomerization domain pathways. This system 
off  ers the opportunity to bacteria to suppress the expression of 
genes whose promoters contain NF-    B and AP-1 motifs, as 
well as possibly other regulatory sequences. 
  Antimicrobial peptide-encoding genes have mosaic pro-
moters characterized by the presence of NF-    B, AP-1, and 
others regulatory boxes. Given our current understanding of 
signaling pathways targeted by the MxiE-regulated eff  ectors, 
these genes are therefore excellent candidates to be regulated 
by the set of eff  ectors under the   mxiE   regulon. This is the case 
for the     -defensin HBD2 whose expression has been shown 
to be mediated through NF-    B, sometimes assisted by AP-1, 
MAPK, and protein kinase C (  40, 41  ). A potential role of 
the JAK2  –  STAT signaling pathway has been suggested in the 
control of HBD1 and HBD3 expression (  32  ). Indeed, the 
HBD3 gene promoter contains transcriptional binding motifs 
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analyzed with the S-Plus ArrayAnalyser software (Insightfull Corporation). 
Preprocessing by Robust Multichip Average (RMA) was applied to process 
individual probe values (perfect match) and to generate summary values for 
each probe set (transcript) (  52  ). As two replicates were done, statistical ana-
lyses were performed using the Local Pool Error test, an algorithm dedicated 
to small number of replicate arrays (  53  ). The P values were adjusted using 
the Bonferroni algorithm. The dChip software was used for hierarchical 
clustering with Euclidean distance and average as a linkage method (  54  ). 
Before clustering, expression values for one gene across all samples were stan-
dardized to produce a mean of zero. Increased or decreased values were then 
ranged compared with that mean. Microarray data have been deposited in 
National Center for Biotechnology Information Gene Expression Omnibus 
(www.ncbi.nlm.nih.gov/projects/geo) and are accessible through GEO 
Series accession no. GSE8636. 
  RNAs isolation and quantitative real-time PCR.     RNAs were isolated 
using the RNeasy Mini kit. RT-PCR reactions were performed on 4-  μ  g 
RNA samples using the SuperScript II reverse transcription (Invitrogen) and 
the oligo(dT)15 primers (Promega) as recommended by the suppliers. Gene-
specific primers were purchased from Proligo (Sigma-Aldrich): HBD1, 
5    -CAGGTGGTAACTTTCTCACAGG-3     and 5    -AATAGAGACATT-
GCCCTCCACT-3    ; HBD2, 5    -GCCATGAGGGTCTTGTATCTC-3     
and 5    -TTAAGGCAGGTAACAGGATCG-3    ; HBD3, 5    -GTGTGTTC-
TGCATGGTGAGAG-3     and 5    -TATAAAGGTTCCAGCCACAGC-3    ; 
LL37, 5    -CGGAAATCTAAAGAGAAGATTGG-3     and 5    -TAGGGCA-
CACACTAGGACTCTG-3    ; CCL20, 5    -GACATAGCCCAAGAACA-
GAAAG-3     and 5    -TAATTGGACAAGTCCAGTGAGG-3    ; CCR6, 
5    -  CAGT      CATCATCTCCAGCTCAAC-3       and 5    -  CTCCGAGACA-
GTCTGGTACTTG-3      . qRT-PCRs were carried out in a 20-  μ  l volume 
containing 8   μ  l of cDNA (diluted at 1/100), specifi  c primers (0.2   μ  M each), 
and 10   μ  l of Power SYBR Green mix (Applied Biosystems). Reactions were 
run on an ABI 7900HT instrument (Applied Biosystems) with conditions of 
the recommended universal thermal cycling parameters. Each reaction was 
run in duplicate. Relative quantifi  cation of gene expression was performed 
using the comparative Ct method. Results were normalized using the 
human     -2-microglobulin (B2M) housekeeping gene. 
  Immunohistological experiments.     Cryostat sections (7   μ  m) were pre-
pared from human intestinal xenografts conserved in OCT. Sections were 
rehydrated, blocked for 30 min in PBS with 1% BSA, and immunostained 
with the following antibodies: polyclonal antibody to   S. fl  exneri   5a LPS, poly-
clonal antibody to human hBD-1 (FL-68; Santa Cruz Biotechnology), poly-
clonal antibody to human hBD-3 (FL-67; Santa Cruz Biotechnology), 
polyclonal antibody to human CCL20 (AF360; R  &  D Systems), and mono-
clonal biotinylated antibody to mouse CD11c (HL3; BD Biosciences). Slides 
were washed twice in PBS before addition of the appropriate peroxidase-
conjugated secondary antibody. Detection was accomplished by addition of 
the liquid DAB Substrate-Chromogen System (Dako). 
  Antimicrobial assays.     Antimicrobial activities of the synthetic human   
  -defensins hBD-1, hBD-2, hBD-3 (PeptaNova), cathelicidin LL37 (Phoenix 
Pharmaceuticals), and the recombinant chemokine CCL20 (PeproTech) were 
tested on the diff  erent   S. fl  exneri   strains, as previously described (  29  ). In brief, 
fresh dilutions of overnight   S. fl  exneri   cultures were subcultured for 2 h, bac-
teria were spun gently, resuspended in DME medium (Invitrogen) containing 
5   μ  g/ml (CCL20) or 50   μ  g/ml (hBD1-3 and LL37) of the relevant peptide, 
and incubated for 2 h at 37  °  C with intermittent shaking, in a 100-  μ  l fi  nal vol-
ume. Because the activity of most antimicrobial factors is antagonized by high 
salt concentrations, DME medium was diluted to 1:2 for these experiments 
(  4  ). Bacteria were incubated for 10 min at room temperature with 10   μ  g/ml 
bis-(1,3-dibutylbarbituric acid)-trimethine oxonol fl  uorescent molecule 
(DiBAC  4  ; Invitrogen), which crosses depolarized bacterial membrane only, 
before acquisition. Analysis of DiBAC  4  -fl  uorescent bacteria was performed 
with a FACSCalibur apparatus (BD Biosciences) using the CellQuest Pro 
software. The mean fl  uorescence is presented in arbitrary fl  uorescent units. 
proper colonization, to control the intensity of the infl  amma-
tory response to achieve optimal tolerance while disconnecting 
the mechanisms of immunosuppression to achieve maximum 
immunogenicity and memory. 
    MATERIALS AND METHODS   
  Bacterial strains and culture conditions.       S. fl  exneri   serotype 5a strains 
were isolated on Congo red agar plates. The invasive wild-type strain M90T 
(  46  ) and its isogenic derivatives, the invasive   mxiE   mutant (  47  ) (impaired for 
the MxiE transcriptional activator regulating expression of several virulence 
plasmid-encoded eff  ectors), the noninvasive   mxiD   mutant (  48  ) (impaired for 
the MxiD protein, a component of the TTSS required for its functionality), 
and the noninvasive plasmid-cured BS176 strain (  46  ) were used. For infec-
tion experiments, strains were cultured overnight in BTCS medium (Difco) 
at 37  °  C with shaking. For human intestinal xenograft infections, overnight 
cultures were directly used. For polarized and diff  erentiated monolayer cell 
infections, after fresh dilutions, subcultures were performed for 2 h to reach 
the exponential phase, spun gently, and used after resuspension of bacteria in 
DME tissue culture medium (Invitrogen). 
  Polarized and diff  erentiated cell monolayer infections.     TC7 (  49  ) and 
HT29 human epithelial cells derived from colonic carcinoma were cultured 
in 6-well plates (1.5   ×   10  6   cells/well) with DME (Invitrogen) supplemented 
with 10% FCS (Invitrogen), 1% nonessential amino acids (Invitrogen), 
100 U/ml penicillin, and 100   μ  g/ml streptomycin (Invitrogen) in 10% CO  2  . 
To obtain polarized and diff  erentiated cell monolayers, cells were grown for 
3 wk to reach full diff  erentiation and polarization. Culture medium was 
changed three times per week. Infections were performed in triplicate in 
DME without serum at a multiplicity of infection (MOI) of 100. When 
specifi  ed, cells were stimulated for 2 h with 20 ng/ml IL-1     (R  &  D Sys-
tems), after which IL-1      –  containing medium was removed and infections 
were performed. To facilitate   S. fl  exneri   infection, the cell culture plates were 
spun gently for 10 min at 1,000 rpm at room temperature, and then stored 
at 37  °  C. After 1 h 30 min of infection, 50   μ  g/ml gentamicin (Invitrogen) 
was added, cells were incubated for the appropriate length of time, washed 
with PBS, and lysed for RNA isolations. Gentamicin assays (  14  ) and lactate 
dehydrogenase assays (CytoTox; Promega) were performed on TC7 or 
HT29 cell monolayers under similar conditions of infection. 
  Human intestinal xenograft infections.     Human intestinal xenografts 
were placed into the subscapular region of 6  –  8-wk-old SCID mice, as previ-
ously described (  50  ). Grafts were allowed to develop for 10 wk before use, 
and then human tissues on mice were infected by direct intraluminal inocu-
lation with 5   ×   10  7     S. fl  exneri   bacteria. A group was mock infected by inocu-
lation with media alone, as a control. At 2 h after infection, animals were 
killed, and grafts were removed and frozen for Trizol RNA isolation (Invit-
rogen), or for immunohistological analysis. In the latter case, they were em-
bedded on OCT compound (Sakura) and frozen in isopentane-dry ice. For 
RNA isolations, a subsequent cleanup was performed using the RNeasy 
Mini kit (QIAGEN). For the transcriptomic and the histological approaches, 
two and four biological replicates were performed, respectively. Animal ex-
periments were done according to the guidelines of the Institut Pasteur  ’  s 
ethical committee for animal use in research. 
  GeneChip hybridization and statistical analysis.     After infections, a sec-
tion of each graft was removed and homogenized with an Ultra-Turrax ap-
paratus (Janke and Kunkel, GmbH and Co.) in 2 ml of Trizol (Invitrogen). 
Total RNA was extracted according to the manufacturer  ’  s instructions and 
cleaned by a subsequent purifi  cation using the RNeasy Mini kit (QIAGEN). 
RNA quantity and quality were analyzed by the Agilent Bioanalyzer (Agi-
lent). The cRNA synthesis, hybridization, and labeling were carried out as 
previously described (  51  ). 10   μ  g of cRNA were fragmented and hybridized 
to the U133A GeneChip Human Array (Aff  ymetrix). After PE-Streptavidin 
staining, arrays were scanned at 488 nm using an argon-iron laser. Data were JEM VOL. 205, May 12, 2008 
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